Edge Wealth Management’s NovoCure NVCR Stock Holding History

Edge Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-80	Closed	-$6K	–	335
2021 Q4	$6K	Hold	80	–	–	﹤0.01%	325
2021 Q3	$9K	Hold	80	–	–	﹤0.01%	316
2021 Q2	$18K	Hold	80	–	–	﹤0.01%	283
2021 Q1	$11K	Hold	80	–	–	﹤0.01%	297
2020 Q4	$14K	Hold	80	–	–	﹤0.01%	263
2020 Q3	$9K	Hold	80	–	–	﹤0.01%	325
2020 Q2	$5K	Hold	80	–	–	﹤0.01%	552
2020 Q1	$5K	Sell	80 -226,524	-100%	-$17.9M	﹤0.01%	480
2019 Q4	$1.78M	Buy	226,604 +226,524	+283,155%	+$18.3M	0.36%	51
2019 Q3	$5K	Hold	80	–	–	﹤0.01%	481
2019 Q2	$5K	Hold	80	–	–	﹤0.01%	482
2019 Q1	$4K	Hold	80	–	–	﹤0.01%	486
2018 Q4	$3K	Hold	80	–	–	﹤0.01%	509
2018 Q3	$4K	Hold	80	–	–	﹤0.01%	529
2018 Q2	$3K	Hold	80	–	–	﹤0.01%	518
2018 Q1	$2K	Hold	80	–	–	﹤0.01%	512
2017 Q4	$1K	Buy	+80	New	+$1.54K	﹤0.01%	507
2017 Q2	–	Sell	-95	Closed	-$1K	–	558
2017 Q1	$1K	Hold	95	–	–	﹤0.01%	484
2016 Q4	$1K	Hold	95	–	–	﹤0.01%	455
2016 Q3	$1K	Hold	95	–	–	﹤0.01%	454
2016 Q2	$1K	Buy	+95	New	+$1.19K	﹤0.01%	435

Other funds holding NVCR

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edge Wealth Management's NVCR Position: Q1 2022 in Review

Edge Wealth Management sold out of NovoCure (NVCR) in Q1 2022, closing a stake of 80 shares — an estimated $6K sold.

Edge Wealth Management first reported a position in NVCR in Q2 2016 and held it in 21 quarters. The position peaked at $1.78M in Q4 2019. 308 funds tracked by Wall St. Rank hold NVCR as of Q1 2022.

Edge Wealth Management reported no remaining NovoCure position as of Q1 2022 after selling out during the quarter.
Edge Wealth Management sold 80 NovoCure shares in Q1 2022, an estimated $6K.
Edge Wealth Management first reported a position in NovoCure in Q2 2016 and held it in 21 quarters.
Edge Wealth Management's NovoCure position peaked at $1.78M in Q4 2019.
308 funds tracked by Wall St. Rank held NovoCure as of Q1 2022.

Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.